Respiratory and CVD Health related
Conditions
Interventions
Formula:oral take CC001 containing 800mg botanical extracts
Control:placebo
Sponsors
Amway (China) R&D Center
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Male or female volunteers aged 18 to 35 years; 2. Live in Wuhan locally within one year after the trial begins; 3. Be able to join in the normal activity; 4. People whose living room has not been decorated for the past two years, and will not be decorated in the next year; 5. Be able to cooperate with experimental research, provide biological specimen, informed consent, volunteer to participate in research.
Exclusion criteria
Exclusion criteria: 1. Psychopath; 2. Be unable to cooperate with experimental research or investigator because of dysgnosia or behavior disorder; 3. The patients have systemic disease(such as pneumonia, tuberculosis, atherosclerosis and other immune systemic diseases which the researchers consider unsuitable for the study; 4. Idiopathic sleep disorder > 1 night/week; 5. drinking alcohol (weekly drinking <1 times per week); 6. With heart disease, chronic obstructive pulmonary disease, asthma, and malignant tumors; 7. People who are unable to join in the normal activity
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lung Function;FENO;blood inflammation factors and enzymes ; | — |
Secondary
| Measure | Time frame |
|---|---|
| heavy metal and PAHs in Urine;Blood lipid profile;gut microbiota; | — |
Countries
China
Contacts
Public ContactLiang Chen
Amway (China) R&D Center
Outcome results
None listed